UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051063
Receipt number R000058226
Scientific Title Accura Balloon dilatation catheter for Percutaneous Balloon Pulmonary Valvuloplasty among Adult Patients
Date of disclosure of the study information 2023/05/15
Last modified on 2023/05/15 16:36:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Accura Balloon dilatation catheter for Percutaneous Balloon Pulmonary Valvuloplasty among Adult Patients- Its protean use

Acronym

Accura Balloon for BPV

Scientific Title

Accura Balloon dilatation catheter for Percutaneous Balloon Pulmonary Valvuloplasty among Adult Patients

Scientific Title:Acronym

Accura Balloon for BPV

Region

Asia(except Japan)


Condition

Condition

Pulmonary valve Stenosis

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the safety and efficacy of the Accura balloon for Balloon Pulmonary Valvuloplasty

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Successful Balloon Pulmonary Valvuloplasty, defined as residual gradient less than 35 mm Hg and absence of any major complication like death, cardiac perforation, tamponade, and bleeding.

Key secondary outcomes

Major complications (death, cardiac perforation, tamponade, and bleeding).
Minor complications (transient hypotension, ventricular premature contraction, and transient bradycardia)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Use of Accura Balloon dilatation catheter for Percutaneous Balloon Pulmonary Valvuloplasty among Adult patients

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

asymptomatic patients with echocardiographic evidence of suitable morphology and maximum instantaneous and mean gradient across the pulmonary valve of more than 60mmHg and 40 mmHg respectively and in symptomatic patients with a maximum instantaneous gradient of more than 50mmHg and mean gradient of more than 30 mmHg.

Key exclusion criteria

associated infundibular stenosis
supravalvular stenosis
associated complex cyanotic disease requiring palliation
more than Grade III pulmonary leak
pulmonary annulus more than 15mm

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Santosh
Middle name Kumar
Last name Sinha

Organization

LPS Institute of Cardiology, GSVM, Kanpur, India

Division name

Department of Cardiology

Zip code

208002

Address

Medical College Campus, GSVM, Swaroop Nagar

TEL

00919670220088

Email

fionasan@rediffmail.com


Public contact

Name of contact person

1st name Najeeb
Middle name Ullah
Last name Sofi

Organization

LPS institute of Cardiology

Division name

Department of Cardiology

Zip code

208002

Address

D 17, Medical College Campus, GSVM, Swaroop Nagar

TEL

00917042132737

Homepage URL


Email

sofinajeeb@gmail.com


Sponsor or person

Institute

LPS Institute of Cardiology
GSVM
Kanpur

Institute

Department

Personal name



Funding Source

Organization

Self Funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

LPS institute of Cardiology

Address

D 17, Medical College Campus, GSVM, Swaroop Nagar

Tel

0091-7042132737

Email

sofinajeeb@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

LPS Institute of Cardiology, GSVM, Kanpur, UP, India 208002


Other administrative information

Date of disclosure of the study information

2023 Year 05 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

43

Results

Successful BPV was done in all 43 patients among which 5 patients had dysplastic valve.
The mean diameter of the annulus was 18.5 mm.

Immediate hemodynamic improvement was observed in 38 patients as peak systolic gradient reduced from 84 to 22 mmHg while 5 patients had <50% reduction of resting gradient though it came down significantly at 6 months.

Fluoroscopy and procedural time were 5.2 min and 22.6 min respectively.

Results date posted

2023 Year 05 Month 15 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Age (years) 21.9 (18- 29)
Sex (Male/Female) 31(72%)/12(28%)
Weight (kg) 32.7 (22.6- 381.)
Height (cm) 139.8 (123.5-157.2)
BSA 1.48 (1.32-1.72)
Clinical presentation
A. Asymtomatic 08(18.6%)

B. Symtomatic 35(81.4%)
a. Dyspnoea 28(65%)
b. Fatigue 18(41%)
c. Palpitation 13(30%)
d. Syncope 3(7%)
e. Evaluation of murmur 5(11.6%)
f. Cyanosis 2(4.5%)

PV morphology
a. Doming 38(88.4%)
b. Dysplastic 5(11.6%)


Peak echocardiographic gradient (mm Hg) 76(52-166)

RV to PA peak catheter pullback gradient (mm Hg) 68(52-159)

RV/Systemic pressure ratio 0.85(0.60-1.3)

Pulmonary annulus diameter (mm) 18.5(10-21)

Balloon/annulus ratio 1.23(1.20-1.28)

Participant flow


Adverse events

Major complications (death, cardiac perforation, tamponade, Bleeding) 0(0%)

Minor complications
a. Transient hypotension 35(81%)
b. Ventricular premature contraction 39(91%)
c. Transient bradycardia 36(84%)

Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 02 Month 12 Day

Date of IRB

2018 Year 02 Month 14 Day

Anticipated trial start date

2018 Year 03 Month 01 Day

Last follow-up date

2022 Year 08 Month 03 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 05 Month 15 Day

Last modified on

2023 Year 05 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058226


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name